Mercer Global Advisors’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.63M Buy
29,051
+3,112
+12% +$286K ﹤0.01% 1062
2025
Q4
$2.33M Sell
25,939
-920
-3% -$87.2K ﹤0.01% 1039
2025
Q3
$2.65M Buy
26,859
+3,752
+16% +$372K ﹤0.01% 923
2025
Q2
$2.11M Buy
23,107
+4,338
+23% +$419K ﹤0.01% 865
2025
Q1
$2.12M Buy
18,769
+1,357
+8% +$145K ﹤0.01% 821
2024
Q4
$1.84M Buy
17,412
+8,083
+87% +$867K ﹤0.01% 859
2024
Q3
$1M Sell
9,329
-426
-4% -$46.5K ﹤0.01% 1015
2024
Q2
$1.05M Sell
9,755
-182
-2% -$21.5K ﹤0.01% 951
2024
Q1
$1.31M Buy
9,937
+1,952
+24% +$244K ﹤0.01% 851
2023
Q4
$972K Sell
7,985
-725
-8% -$80.9K ﹤0.01% 986
2023
Q3
$977K Sell
8,710
-1,087
-11% -$138K ﹤0.01% 950
2023
Q2
$1.43M Sell
9,797
-94
-1% -$12.8K 0.01% 828
2023
Q1
$1.28M Buy
9,891
+567
+6% +$71.2K 0.01% 824
2022
Q4
$1.19M Buy
9,324
+1,173
+14% +$136K 0.01% 848
2022
Q3
$852K Sell
8,151
-1,587
-16% -$174K 0.01% 913
2022
Q2
$1.02M Sell
9,738
-784
-7% -$93K 0.01% 831
2022
Q1
$1.35M Sell
10,522
-2,173
-17% -$262K 0.01% 778
2021
Q4
$1.57M Buy
12,695
+1,523
+14% +$199K 0.01% 709
2021
Q3
$1.59M Buy
11,172
+917
+9% +$135K 0.01% 695
2021
Q2
$1.6M Buy
10,255
+506
+5% +$82K 0.01% 652
2021
Q1
$1.51M Sell
9,749
-121
-1% -$18.7K 0.01% 631
2020
Q4
$1.48M Sell
9,870
-571
-5% -$80.6K 0.02% 503
2020
Q3
$1.38M Sell
10,441
-2,995
-22% -$391K 0.02% 477
2020
Q2
$1.56M Sell
13,436
-1,544
-10% -$178K 0.03% 376
2020
Q1
$1.47M Buy
14,980
+919
+7% +$120K 0.03% 378
2019
Q4
$2.04M Buy
14,061
+681
+5% +$94K 0.04% 335
2019
Q3
$1.78M Buy
13,380
+1,291
+11% +$167K 0.04% 324
2019
Q2
$1.38M Buy
12,089
+1,505
+14% +$176K 0.04% 376
2019
Q1
$1.31M Buy
+10,584
New +$1.2M 0.05% 333

Other funds holding ZBH

Mercer Global Advisors's ZBH Position: Q1 2026 in Review

Mercer Global Advisors increased its Zimmer Biomet (ZBH) stake by 12% in Q1 2026, buying an estimated $286K and bringing the position to 29,051 shares worth $2.63M. The position accounts for ﹤0.01% of the portfolio, ranked #1062.

Mercer Global Advisors first reported a position in ZBH in Q1 2019 and has held it in 29 quarters since. The position peaked at $2.65M in Q3 2025. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • Mercer Global Advisors held 29,051 shares of Zimmer Biomet worth $2.63M as of Q1 2026.
  • Mercer Global Advisors bought 3,112 Zimmer Biomet shares in Q1 2026, an estimated $286K.
  • Zimmer Biomet made up ﹤0.01% of Mercer Global Advisors's portfolio in Q1 2026, its #1062 holding.
  • Mercer Global Advisors first reported a position in Zimmer Biomet in Q1 2019 and has held it in 29 quarters since.
  • Mercer Global Advisors's Zimmer Biomet position peaked at $2.65M in Q3 2025.
  • 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Mercer Global Advisors's 13F filing for Q1 2026, filed 15 May 2026.